Associated Papers
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients.
Ungaro R et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019
Prevalence of Integrase Strand Transfer Inhibitors Resistance Mutations in Integrase Strand Transfer Inhibitors-Naive and -Experienced HIV-1 Infected Patients: A Single Center Experience.
De Francesco MA et al.
Aids Research and Human Retroviruses, 2018
Dolutegravir-based regimen maintains virological success in a patient with archived mutations to integrase inhibitors.
Mazzuti L et al.
Aids (london, England), 2017
Substitutions at amino acid positions 143, 148, and 155 of HIV-1 integrase define distinct genetic barriers to raltegravir resistance in vivo.
Fransen S et al.
Journal of Virology, 2012
Elvitegravir overcomes resistance to raltegravir induced by integrase mutation Y143.
Métifiot M et al.
Aids (london, England), 2011
Effect of raltegravir resistance mutations in HIV-1 integrase on viral fitness.
Hu Z et al.
Journal of Acquired Immune Deficiency Syndromes (1999), 2010
Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir.
Métifiot M et al.
Biochemistry, 2010
Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy.
Charpentier C et al.
Hiv Medicine, 2008
Select a paper to view details